21st Austria weekly - Marinomed 22/05/2024 [pic1]Marinomed: Biotech AG VSE:MARI announces revenues of EUR 0.7 million recorded in the first quarter 2024. After observing record from Carragelose product sales heavily influenced by SARS-CoV-2 pandemic over past years revenue 2024 has declined to levels observed before pandemic. This decline is mostly due high inventories and return seasonality causing a drop customer demand. Due cost-conscious cash management equivalents stood at 1.9 compared 2.6 end 2023. The operating result EBIT -1.9 Q1 2023: -1.4 million loss for period amounted -2.1 million. “Although we are making constant progress working on several initiatives parallel situation remains challenging. Revenues
21st Austria weekly - Marinomed 07/02/2024 [pic1]Marinomed: Biotech AG has enrolled the first patient in a clinical study to investigate lubricating properties of Carragelose eye drops patients diagnosed with mild moderate dry disease. While product holds valid certification under Medical Device Directive MDD supports switch new Regulation MDR. are planned launch 2024. Furthermore business development process for partnering outside is full swing. Next drops also allergen-blocking nasal spray published data demonstrating effectiveness prophylactic treatment allergic rhinitis symptoms nose on pre-print server October
21st Austria weekly - Vienna Insurance Group RBI UBM 31/01/2024 [pic1]VIG: Günter Geyer informed that he will no longer be available as Chairman of the Supervisory Board Group VIG after his current mandate expires. His term office ends on 24 May 2024 with Annual General Meeting resolving 2023 financial year. has played a key role in development leading insurance group Central-
21st Austria weekly - Wienerberger Valneva Palfinger 09/11/2023 [pic1]Wienerberger: Operating in a persistently challenging macroeconomic environment provider of innovative ecological solutions for the entire building envelope successfully held its ground third quarter 2023 sustaining good performance first two quarters. Compared to record-breaking year 2022 company generated strong results especially view decline demand all relevant end markets with third-quarter revenues at group level € 3 286 million Q3 2022: 3 848 million and operating EBITDA 665 820 million. The continuation established self-help program aimed earnings growth efficiency enhancements contributed satisfactory amount earnings. These solid results once more demonstrate resilience sustainable diversified business model. Given position proven resilience combined profitability-increasing measures is confident delivering very 2023 confirms target 800-820 million.Wienerberger: performance: 1.91% Valnev
21st Austria weekly - Andritz Immofinanz 20/06/2023 [pic1]Andritz: Hungrana a leading sugar producer based in Hungary an subsidiary of Austrian sugar starch and fruit company Agrana has recently invested tailor-made biomass boiler to support its operations. This investment is part Hungrana s ongoing commitment sustainability reducing environmental impact while increasing production capacities. Andritz TEP d.o.o provider complete power plant solutions one the European manufacturers was chosen for design production delivery associated civil works erection all related equipment. Hungrana already operates several boilers using different fuels. The new wood chips from will further increase Hungrana’s steam capacity renewable resources. Boiler start June with construction work planned September.Andritz: